208 related articles for article (PubMed ID: 29107298)
21. Serum Levels of Soluble CD26/Dipeptidyl Peptidase-IV in Type 2 Diabetes Mellitus and Its Association with Metabolic Syndrome and Therapy with Antidiabetic Agents in Malaysian Subjects.
Ahmed RH; Huri HZ; Al-Hamodi Z; Salem SD; Muniandy S
PLoS One; 2015; 10(10):e0140618. PubMed ID: 26474470
[TBL] [Abstract][Full Text] [Related]
22. A haplotype in the dipeptidyl peptidase 4 gene impacts glycemic-related traits of Brazilian older adults.
Alves ES; Tonet-Furioso AC; Alves VP; Moraes CF; Pérez DIV; Bastos IMD; Córdova C; Nóbrega OT
Braz J Med Biol Res; 2022; 55():e12148. PubMed ID: 36197412
[TBL] [Abstract][Full Text] [Related]
23. Expansion of a CD26low Effector TH Subset and Reduction in Circulating Levels of sCD26 in Stable Allergic Asthma in Adults.
Nieto-Fontarigo JJ; González-Barcala FJ; San-José ME; Cruz MJ; Linares T; Soto-Mera MT; Valdés-Cuadrado L; García-González MA; Andrade-Bulos LJ; Arias P; Nogueira M; Salgado FJ
J Investig Allergol Clin Immunol; 2018; 28(2):113-125. PubMed ID: 29297467
[TBL] [Abstract][Full Text] [Related]
24. Increased Plasma Dipeptidyl Peptidase-4 (DPP4) Activity Is an Obesity-Independent Parameter for Glycemic Deregulation in Type 2 Diabetes Patients.
Sarkar J; Nargis T; Tantia O; Ghosh S; Chakrabarti P
Front Endocrinol (Lausanne); 2019; 10():505. PubMed ID: 31402899
[No Abstract] [Full Text] [Related]
25. The effects of DPP4 inhibitors on the levels of plasma catecholamines and their metabolites in patients with type 2 diabetes.
Kim TH; Lee K; Park IB; Choi CS; Ahn TH; Lee DH
Diabetes Res Clin Pract; 2019 Oct; 156():107832. PubMed ID: 31513823
[TBL] [Abstract][Full Text] [Related]
26. Degranulation of human cytotoxic lymphocytes is a major source of proteolytically active soluble CD26/DPP4.
Lettau M; Dietz M; Vollmers S; Armbrust F; Peters C; Dang TM; Chitadze G; Kabelitz D; Janssen O
Cell Mol Life Sci; 2020 Feb; 77(4):751-764. PubMed ID: 31300870
[TBL] [Abstract][Full Text] [Related]
27. Comparison between SGLT2 inhibitors and DPP4 inhibitors added to insulin therapy in type 2 diabetes: a systematic review with indirect comparison meta-analysis.
Min SH; Yoon JH; Hahn S; Cho YM
Diabetes Metab Res Rev; 2017 Jan; 33(1):. PubMed ID: 27155214
[TBL] [Abstract][Full Text] [Related]
28. Association of Plasma DPP4 Activity With Mild Cognitive Impairment in Elderly Patients With Type 2 Diabetes: Results From the GDMD Study in China.
Zheng T; Qin L; Chen B; Hu X; Zhang X; Liu Y; Liu H; Qin S; Li G; Li Q
Diabetes Care; 2016 Sep; 39(9):1594-601. PubMed ID: 27371673
[TBL] [Abstract][Full Text] [Related]
29. Real-life comparison of DPP4-inhibitors with conventional oral antidiabetics as add-on therapy to metformin in elderly patients with type 2 diabetes: the HYPOCRAS study.
Penfornis A; Bourdel-Marchasson I; Quere S; Dejager S
Diabetes Metab; 2012 Dec; 38(6):550-7. PubMed ID: 22996038
[TBL] [Abstract][Full Text] [Related]
30. Increased plasma DPP4 activity is predictive of prediabetes and type 2 diabetes onset in Chinese over a four-year period: result from the China National Diabetes and Metabolic Disorders Study.
Zheng T; Gao Y; Baskota A; Chen T; Ran X; Tian H
J Clin Endocrinol Metab; 2014 Nov; 99(11):E2330-4. PubMed ID: 25029421
[TBL] [Abstract][Full Text] [Related]
31. Dipeptidyl peptidase 4 inhibitors attenuate cardiac ischaemia-reperfusion injury in rats with diabetes mellitus type 2.
Bradic J; Milosavljevic I; Bolevich S; Litvitskiy PF; Jeremic N; Bolevich S; Zivkovic V; Srejovic I; Jeremic J; Jovicic N; Mitrovic S; Jakovljevic V
Clin Exp Pharmacol Physiol; 2021 Apr; 48(4):575-584. PubMed ID: 33352623
[TBL] [Abstract][Full Text] [Related]
32. Association of Plasma DPP4 Activity and Brain-Derived Neurotrophic Factor With Moderate to Severe Depressive Symptoms in Patients With Type 2 Diabetes: Results From a Cross-Sectional Study.
Zheng T; Ge B; Qin L; Chen B; Tian L; Gao Y; Xiao L; Hu X; Pan H; Chen Y
Psychosom Med; 2020 May; 82(4):350-358. PubMed ID: 32358323
[TBL] [Abstract][Full Text] [Related]
33. Sitagliptin inhibit human lymphocytes proliferation and Th1/Th17 differentiation in vitro.
Pinheiro MM; Stoppa CL; Valduga CJ; Okuyama CE; Gorjão R; Pereira RM; Diniz SN
Eur J Pharm Sci; 2017 Mar; 100():17-24. PubMed ID: 28065853
[TBL] [Abstract][Full Text] [Related]
34. Dipeptidyl peptidase 4 inhibitors and their potential immune modulatory functions.
Shao S; Xu Q; Yu X; Pan R; Chen Y
Pharmacol Ther; 2020 May; 209():107503. PubMed ID: 32061923
[TBL] [Abstract][Full Text] [Related]
35. Oxidative stress-mediated influence of plasma DPP4 activity to BDNF ratio on mild cognitive impairment in elderly type 2 diabetic patients: results from the GDMD study in China.
Zheng T; Liu H; Qin L; Chen B; Zhang X; Hu X; Xiao L; Qin S
Metabolism; 2018 Oct; 87():105-112. PubMed ID: 29572131
[TBL] [Abstract][Full Text] [Related]
36. DPP4 Regulates the Th17/IL-17 Axis and Accelerates Epithelial Mesenchymal Transition to Promote Ovalbumin-Induced Asthma in Female C57BL/6J Mice.
Li L; Ling F; Li R; Jiang Y; Long H; Xiao B; Wu J; Long Z; Ma L
Front Biosci (Landmark Ed); 2023 Dec; 28(12):342. PubMed ID: 38179747
[TBL] [Abstract][Full Text] [Related]
37. Biological function of dipeptidyl peptidase-4 on type 2 diabetes patients and diabetic mice.
Qiao J; Li L; Ma Y; Shi R; Teng M
Curr Res Transl Med; 2019 Aug; 67(3):89-92. PubMed ID: 30591375
[TBL] [Abstract][Full Text] [Related]
38. The serum level of soluble CD26/dipeptidyl peptidase 4 increases in response to acute hyperglycemia after an oral glucose load in healthy subjects: association with high-molecular weight adiponectin and hepatic enzymes.
Aso Y; Terasawa T; Kato K; Jojima T; Suzuki K; Iijima T; Kawagoe Y; Mikami S; Kubota Y; Inukai T; Kasai K
Transl Res; 2013 Nov; 162(5):309-16. PubMed ID: 23994650
[TBL] [Abstract][Full Text] [Related]
39. Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors.
Mulvihill EE; Drucker DJ
Endocr Rev; 2014 Dec; 35(6):992-1019. PubMed ID: 25216328
[TBL] [Abstract][Full Text] [Related]
40. Serum dipeptidyl peptidase 4 activity in children with type 1 diabetes mellitus.
Iwabuchi A; Kamoda T; Saito M; Nozue H; Izumi I; Hirano T; Sumazaki R
J Pediatr Endocrinol Metab; 2013; 26(11-12):1093-7. PubMed ID: 23817599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
